The board meeting for Apellis Pharma Inc is scheduled for today, for the purpose of Apellis Pharmaceuticals Inc First Quarter Earnings Conference Call for 2026See details
Apellis Pharma Inc has a share price target of US$ 41, revenue growth forecast of -7.8%, and profit growth estimate of -508.8% for FY26, based on top 20 analyst calls.